retatrutide phase 2 results 2024 2025 press release 💉 may be redefining obesity treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Triple hormone receptor agonist retatrutide

HDAC6 inhibitor Ricoliostat: HDAC6 inhibitors can promote the degradation of protein aggregates or protect neurons from oxidative stress, hence can be used as possible drugs for treating peripheral neuropathy

I designed this schematic on BioRender to visualize what I think is happening to my patients

If you eat too soon after taking the medication, food can surround it and prevent the drug from touching the stomach lining and working the way it needs to

Front Microbiol 15:1466024 Monier MN (2020) Efficacy of dietary exogenous enzyme supplementation on growth performance, antioxidant activity, and digestive enzymes of common carp ( Cyprinus carpio ) fry